FDA Drug Safety Communication: FDA approves label changes for use of general anaesthetic and sedation drugs in children younger than 3 years -

FDA Drug Safety Communication: FDA approves label changes for use of general anaesthetic and sedation drugs in children younger than 3 years
Information type: Safety alerts
Source: US Food and Drug Administration
Specialities: Anaesthesia and pain | Paediatric and neonatal medicine
Summary
The FDA has approved changes to the labels of general anaesthetic and sedation drugs, after warning that their repeated or lengthy use during surgeries or procedures in children <3 yr or in pregnant women during their 3rd trimester may affect the development of children’s brains.
UKMi comment
The original communication from the FDA, available at the link below, includes a summary of the data.
Related links: FDA Drug Safety Communication from December 2016